Optimal selective sentinel lymph node dissection in primary malignant melanoma

Archives of Surgery

Volumn 132, Issue 6, 1997, Pages 666-673

  Leong, Stanley P L ^a,c   Steinmetz, Ina ^a   Habib, Fahim A ^a   McMillan, Alex ^b   Gans, Jason Z ^a   Allen Jr , Robert E ^a   Marita, Eugene T ^a   El Kadi, Mohamed ^a   Epstein, Howard D ^b   Kashani Sabet, Mohammed ^b   Sagebiel, Richard W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXCISION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 0030966641     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430300108021     Document Type: Article

References (28)

1. Balch CM, Soong S-J, Mjrad TM, Ingalss AL, Maddox WA. A multifactorial analysis of melanoma, III: prognostic factors In melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377-388.
2. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results and controversies, J Clin Oncol. 1988;6:163-172.
3. Balch CM, Soong S-J, Bartolucci AA, et al, Efficacy of an elective regional lymph node dissection of 1- to 4-mm thick melanomas for patients 60 years of age and younger, Ann Surg. 1996;224:255-266.
4. Gallery C, Cochran AJ, Roe DJ, et al, Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg. 1982;196:69-75.
5. Cohen MH, Ketcham AS, Felix EL. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg. 1977;186:635-642.
6. Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg. 1977;186:201-209.
7. McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery. 1964; 56:512-518.
8. B. Meyer CM, Lecklitner ML, Logic JR, Balch CE, Bessey PQ, Tauxe WN. Technetium- 99m sulfur colloid cutaneous lymphoscintigrapny in the management of trun- cal melanoma. Radiology. 1979;131:205-209.
9. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg. 1992;127:392-399.
10. Morton DL, Wen D-R, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. Surg Oncol Clin North Am. 1992;1:247-259.
11. Reintgen DS, Cruse CW, Wells K. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
12. Reintgen DS. Changing standards of surgical care for melanoma patients. Ann Surg Oncol. 1996;3:327-328.
13. Roses DF, Provet JA, Harris MN, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg, 1985;201:103-107.
14. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results, Cancer. 1978;41:948-956.
15. Veronesi U, Adamus J, Bandiera DC. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med. 1977;297:627-630.
16. Karakousis C, Surgical treatment of malignant melanoma. In: Leong SPL, ed. Cutaneous Malignant Melanoma. Philadelphia, Pa: WB Saunders Co; 1996.
17. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-466.
18. Cabanas RM. Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am. 1992;19:267-276.
19. Alex JC, Krag DN. Gamma-probe-guided localization of lymph nodes. Surg Oncol. 1993;2:137-144.
20. Fee HJ, Robinson D, Sample WF, Graham SL, Holmes CE, Morton DL. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study, Surgery. 1978;84:626-632.
21. Lamki LM, Logic JR. Defining lymphatic drainage patterns with cutaneous lymphoscintigraphy. In: Balch C, Houghton A, Milton GW M, Sober J, Soong SJ, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: JB Lipplncott; 1992;367-675.
22. Sullivan DC, Croker BP, Harris CC, Deery P, Seigler HF. Lymphoscintigraphy in malignant melanoma: 99m Tc antimony sulfur colloid. AJR Am J Roentgenol. 1981;137:847-851.
23. Albertini JJ, Cruse WC, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification in melanoma patients. Ann Surg. 1996;223:217-224.
24. Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging of malignant melanoma, Arch Surg, 1995;130:654-658.
25. Ross MI, Reintgen DS, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol. 1993;9:219-223.
26. Thompson JR, McCarthy WH, Robinson E, Sentinel lymph node biopsy in 102 patients with clinical stage I melanoma undergoing elective lymph node dissection. Presented at the Society of Surgical Oncology 47th Cancer Symposium; 1994; Houston, Tex.
27. Kirkwood JM, Strawderman MH, Ernstoff MS. lnterferon-alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial, EST 1684. J Clin Oncol. 1996;14:7-17.
28. Wang X, Heller R, Van Voorheis N. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;22u:768-774.